Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults

Table 4 Lipid profile

Lipid profile	Group	Baseline period	Ingestion period	P value
Cholesterol (mg/dL)	Probiotic-treated	194.93 ± 37.64	192.20 ± 36.55	0.462
	Placebo	193.70 ± 29.47	192.37 ± 29.75	0.412
Triglyceride (mg/dL)	Probiotic-treated	151.50 ± 63.92	166.83 ± 75.02	0.162
	Placebo	191.40 ± 133.60	187.73 ± 111.58	0.542
HDL (mg/dL)	Probiotic-treated	40.33 ± 9.77	40.00 ± 9.28	0.691
	Placebo	39.93 ± 7.29	40.60 ± 8.18	0.391
LDL (mg/dL)	Probiotic-treated	141.43 ± 32.17	136.97 ± 33.12	0.182
	Placebo	134.50 ± 24.84	133.50 ± 27.06	0.711
Ratio of LDL/HDL	Probiotic-treated	3.63 ± 0.95	3.55 ± 0.87	0.381
	Placebo	3.44 ± 0.70	3.39 ± 0.84	0.611

¹Paired t-test.

²Wilcoxon signed-rank test. A significantly different (P < 0.05). LDL: Low-density lipoprotein; HDL: High-density lipoprotein.